← brief for 2026-09-30 · Slowing decline
Cardiorenal effects of SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal mineralocorticoid receptor antagonists in type 2 diabetes: a systematic review and meta-analysis
Key takeaways
This review combined data from many large trials. It looked at three types of diabetes drugs. The results show these drugs help protect the heart and kidneys. This is a strong finding based on a large amount of evidence.
Who did this work
Yavuz Ayar (Sağlık Bilimleri Üniversitesi) · Serdar Kahvecioğlu (Sağlık Bilimleri Üniversitesi) · Nimet Aktaş (Sağlık Bilimleri Üniversitesi) · Özger Akarsu (Sağlık Bilimleri Üniversitesi) · Nurhan Bilen (Sağlık Bilimleri Üniversitesi)
Source
Article · OpenAlex, CKD works · 2026-09-29
https://doi.org/10.1186/s12902-026-02586-3